KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Range Low Price High Price Comment
30 days $81.00 $93.35 Thursday, 25th Apr 2024 BMRN stock ended at $82.17. This is 9.90% less than the trading day before Wednesday, 24th Apr 2024. During the day the stock fluctuated 7.14% from a day low at $81.00 to a day high of $86.78.
90 days $81.00 $94.15
52 weeks $76.02 $99.55

Historical BioMarin Pharmaceutical Inc. prices

Date Open High Low Close Volume
Aug 15, 2023 $90.20 $91.16 $89.72 $90.67 582 458
Aug 14, 2023 $89.29 $90.77 $89.01 $90.29 688 058
Aug 11, 2023 $90.57 $90.78 $88.94 $89.41 993 103
Aug 10, 2023 $93.21 $93.32 $89.78 $90.91 1 325 079
Aug 09, 2023 $91.29 $94.06 $91.24 $93.23 1 679 612
Aug 08, 2023 $88.29 $90.86 $87.93 $90.62 1 394 204
Aug 07, 2023 $88.10 $88.17 $87.25 $87.83 817 015
Aug 04, 2023 $87.88 $89.44 $87.88 $88.54 1 037 382
Aug 03, 2023 $88.37 $88.54 $87.69 $87.74 922 136
Aug 02, 2023 $88.85 $89.62 $87.16 $88.39 1 105 230
Aug 01, 2023 $87.00 $89.08 $84.65 $89.00 3 175 391
Jul 31, 2023 $87.94 $88.05 $87.07 $87.93 1 320 641
Jul 28, 2023 $87.31 $87.72 $86.25 $87.61 1 170 613
Jul 27, 2023 $87.77 $87.78 $86.06 $86.56 1 167 483
Jul 26, 2023 $87.65 $88.04 $86.91 $87.27 936 013
Jul 25, 2023 $87.54 $88.17 $87.46 $87.83 857 529
Jul 24, 2023 $87.58 $88.58 $87.34 $87.41 853 517
Jul 21, 2023 $87.91 $88.30 $87.38 $87.72 1 174 281
Jul 20, 2023 $86.91 $87.88 $86.63 $87.54 815 492
Jul 19, 2023 $86.93 $87.60 $86.33 $87.08 870 715
Jul 18, 2023 $86.66 $87.09 $85.66 $86.28 1 173 909
Jul 17, 2023 $85.87 $87.36 $85.50 $86.67 933 006
Jul 14, 2023 $85.89 $86.61 $84.67 $85.87 1 264 075
Jul 13, 2023 $85.80 $86.10 $84.86 $85.71 861 788
Jul 12, 2023 $85.35 $86.05 $84.49 $85.24 1 314 306
Click to get the best stock tips daily for free!

About BioMarin Pharmaceutical Inc.

BioMarin Pharmaceutical. BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-acetylgalactosamine 4-sulfatase for patients with MPS VI; and Kuvan, a proprietary synthetic oral form o... BMRN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT